NASDAQ: CODXCo Diagnostics Inc Stock Ownership - Who owns Co Diagnostics?
Insider buying vs selling
Have Co Diagnostics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brian Lee Brown | Chief Financial Officer | 2023-05-23 | 26,057 | $1.32 | $34.40kSell |
| Dwight H. Egan | Chief Executive Officer | 2023-05-23 | 32,103 | $1.32 | $42.38kSell |
| Brian Lee Brown | Chief Financial Officer | 2023-03-20 | 3,000 | $1.90 | $5.70kBuy |
| Brian Lee Brown | Chief Financial Officer | 2022-11-23 | 18,187 | $3.47 | $63.11kSell |
| Dwight H. Egan | Chief Executive Officer | 2022-11-23 | 32,110 | $3.47 | $111.42kSell |
CODX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CODX insiders and whales buy or sell their stock.
CODX Shareholders
What type of owners hold Co Diagnostics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Brent Satterfield | 7.52% | 2,275,000 | $2.37M | Insider |
| America 2030 Capital LLC | 7.50% | 2,269,795 | $2.36M | Insider |
| Vanguard Group Inc | 5.89% | 1,781,283 | $1.85M | Institution |
| Reagents LLC | 5.77% | 1,746,796 | $1.82M | Insider |
| Legends Capital Group LLC | 4.30% | 1,300,344 | $1.35M | Insider |
| Renaissance Technologies LLC | 2.14% | 648,300 | $674.23k | Institution |
| Morgan Stanley | 1.72% | 521,238 | $542.09k | Institution |
| Blackrock Inc | 1.66% | 501,607 | $521.67k | Institution |
| Bridgeway Capital Management LLC | 1.14% | 345,900 | $359.74k | Institution |
| Geode Capital Management LLC | 1.06% | 319,494 | $332.27k | Institution |
CODX vs Diagnostic & Research Stocks
Co Diagnostics Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.